4.6 Letter

Challenges, Perceptions, and Readiness of Oncology Clinicians for the MACRA Quality Payment Program

Journal

JAMA ONCOLOGY
Volume 4, Issue 2, Pages 252-253

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamaoncol.2017.3773

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Meeting Abstract Oncology

Referral patterns and treatment preferences in patients with advanced prostate cancer (aPC): Differences between medical oncologists and urologists

Ajeet Gajra, Skyler Hime, Yolaine Jeune-Smith, Amy Russell, Bruce A. Feinberg

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Medicine, General & Internal

Comparison of Solid Tumor Treatment Response Observed in Clinical Practice With Response Reported in Clinical Trials

Bruce A. Feinberg, Marjorie E. Zettler, Andrew J. Klink, Choo H. Lee, Ajeet Gajra, Jonathan K. Kish

Summary: This study evaluated the feasibility and validity of a novel real-world RECIST method in assessing tumor burden in heterogeneous patient populations undergoing treatment in clinical practice. The findings suggest that physician-recorded assessments overestimate treatment response, while real-world RECIST-based assessments provide better approximations of tumor response compared to those reported in clinical trials.

JAMA NETWORK OPEN (2021)

Correction Medicine, Research & Experimental

Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States (vol 38, pg 2213, 2021)

Sarah S. Mougalian, Jonathan K. Kish, Jingchuan Zhang, Djibril Liassou, Bruce A. Feinberg

ADVANCES IN THERAPY (2021)

Correction Medicine, Research & Experimental

Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States (Jan, 10.1007/s12325-020-01613-6, 2021)

Sarah S. Mougalian, Jonathan K. Kish, Jingchuan Zhang, Djibril Liassou, Bruce A. Feinberg

ADVANCES IN THERAPY (2021)

Meeting Abstract Oncology

Real-world treatment patterns and clinical effectiveness of eribulin in HR+/HER2-metastatic breast cancer patients in the United States

S. S. Mougalian, J. Zhang, J. K. Kish, M. E. Zettler, B. A. Feinberg

ANNALS OF ONCOLOGY (2021)

Meeting Abstract Oncology

Tafasitamab plus lenalidomide versus lenalidomide monotherapy in transplant-ineligible patients with R/R DLBCL (RE-MIND)

Grzegorz Nowakowski, Thomas Rodgers, Dario Marino, Maurizio Frezzato, Anna Maria Barbui, Claudia Castellino, Erika Meli, Nathan H. Fowler, Bruce Feinberg, Sascha Tillmanns, Stephan Parche, Gunter Fingerle-Rowson, Mark Winderlich, Sumeet Ambarkhane, Gilles Salles, Pier Luigi Zinzani

ANNALS OF ONCOLOGY (2021)

Meeting Abstract Economics

CHANGE AND OPPORTUNITY: US COMMUNITY RHEUMATOLOGISTS' PERCEPTIONS OF AND PLANS TO ADDRESS EVOLVING INDUSTRY DYNAMICS

S. Fortier, Y. Jeune-Smith, A. Gajra, B. Feinberg

VALUE IN HEALTH (2021)

Meeting Abstract Economics

COMMUNITY ONCOLOGISTS' EXPERIENCE AND PERCEPTIONS OF CANCER SURVIVORSHIP

A. Gajra, M. Zettler, Y. Jeune-Smith, B. Feinberg

VALUE IN HEALTH (2021)

Meeting Abstract Economics

APPLICATION OF AUGMENTED INTELLIGENCE (AI) IN ONCOLOGY: A PHYSICIAN PERSPECTIVE

A. Gajra, M. Zettler, Graham A. C. Russell, B. Feinberg

VALUE IN HEALTH (2021)

Meeting Abstract Economics

THE IMPACT OF SOCIAL DETERMINANTS OF HEALTH ON CANCER CARE: A SURVEY OF COMMUNITY ONCOLOGISTS

M. Zettler, B. Feinberg, Y. Jeune-Smith, A. Gajra

VALUE IN HEALTH (2021)

Meeting Abstract Economics

PATIENT-REPORTED OUTCOME LABELING FOR RHEUMATOID ARTHRITIS DRUGS APPROVED IN THE UNITED STATES: 2010-2019

M. Zettler, C. Brown-Bickerstaff, K. Savill, A. Gajra, B. Feinberg

VALUE IN HEALTH (2021)

Meeting Abstract Oncology

Pneumonitis Following Durvalumab: A Real-World Analysis in Patients with Lung Cancer and Other Tumor Types

A. Gajra, M. Zettler, J. Kish, B. Feinberg

JOURNAL OF THORACIC ONCOLOGY (2021)

Meeting Abstract Oncology

Evolution of prescribing trends for HR+/HER2-metastatic breast cancer (mBC) in a post-CDK4/6i world

Bruce Feinberg, Igoni Dokubo, Jeff Wojtynek, Jonathan Kish

CANCER RESEARCH (2021)

Meeting Abstract Oncology

Effectiveness of eribulin in poor prognosis subgroups of metastatic breast cancer (mBC) patients (elderly, African Americans, and patients with liver metastases) in the United States

Sarah S. Mougalian, Jonathan K. Kish, Jingchuan Zhang, Djibril Liassou, Bruce A. Feinberg

CANCER RESEARCH (2021)

No Data Available